GlaxoSmithKline PLC — Director's Dealing 2013

Jan 10, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 3106V

GlaxoSmithKline PLC

10 January 2013

Notification of Transactions of Directors, Persons Discharging

Managerial Responsibility or Connected Persons

The Administrators of the GlaxoSmithKline 2009 Deferred Annual Bonus Plan (the Plan) notified the Company and the under-mentioned persons on 10 January 2013 of the following increases in their interests in Ordinary Shares and American Depositary Shares (ADSs) at a price of 1381 pence per Ordinary Share and $44.288 per ADS following the re-investment of dividends paid to shareholders on 3 January 2013.

Mrs D P Connelly	Acquisition of 27.164 ADSs under the personal contribution element of the Plan.
	Acquisition of 27.820 ADSs under the matching element of the Plan (Company contribution).
Mr M Dunoyer	Acquisition of 39.000 Ordinary Shares under the personal contribution element of the Plan.
	Acquisition of 39.670 Ordinary Shares under the matching element of the Plan (Company contribution).
Mr W C Louv	Acquisition of 28.873 ADSs under the personal contribution element of the Plan.
	Acquisition of 29.500 ADSs under the matching element of the Plan (Company contribution).

The afore-mentioned individuals have elected to participate in the Plan in respect of their 2010 and 2011 bonus on a post-tax basis. The notional dividends accrued under the matching element will be paid out in proportion to the percentage of the participant's deferred annual bonus matching award holdings that will vest following the end of the relevant three year measurement period.

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

V A Whyte

Company Secretary

10 January 2013

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSQBLFFXFFEBBQ